ICLN vs. PBE
ICLN (iShares Global Clean Energy ETF) and PBE (Invesco Dynamic Biotechnology & Genome ETF) are both exchange-traded funds - ICLN is a Alternative Energy Equities fund tracking the S&P Global Clean Energy Index, while PBE is a Health & Biotech Equities fund tracking the Dynamic Biotech & Genome Intellidex Index (AMEX). Both are passively managed. Over the past 10 years, ICLN returned 11.52%/yr vs 8.90%/yr for PBE. A 0.50 correlation means they provide meaningful diversification when combined. ICLN charges 0.39%/yr vs 0.59%/yr for PBE.
Performance
ICLN vs. PBE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ICLN achieves a 28.34% return, which is significantly higher than PBE's 3.32% return. Over the past 10 years, ICLN has outperformed PBE with an annualized return of 11.52%, while PBE has yielded a comparatively lower 8.90% annualized return.
ICLN
- 1D
- 0.80%
- 1M
- -3.23%
- YTD
- 28.34%
- 6M
- 28.17%
- 1Y
- 61.48%
- 3Y*
- 5.46%
- 5Y*
- -0.17%
- 10Y*
- 11.52%
PBE
- 1D
- 0.81%
- 1M
- 4.85%
- YTD
- 3.32%
- 6M
- 5.17%
- 1Y
- 34.13%
- 3Y*
- 10.91%
- 5Y*
- 2.31%
- 10Y*
- 8.90%
ICLN vs. PBE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ICLN iShares Global Clean Energy ETF | 28.34% | 47.05% | -25.72% | -20.41% | -5.43% | -24.18% | 141.82% | 44.36% | -9.03% | 21.47% |
PBE Invesco Dynamic Biotechnology & Genome ETF | 3.32% | 24.84% | 1.10% | 3.71% | -10.83% | 1.54% | 25.66% | 18.65% | -0.19% | 22.28% |
Correlation
The correlation between ICLN and PBE is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.32 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.42 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.50 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.49 |
Correlation (All Time) Calculated using the full available price history since Jun 25, 2008 | 0.50 |
The correlation between ICLN and PBE shifts across timeframes, from 0.32 (1 year) to 0.50 (all time), reflecting how their relationship changes across market environments.
ICLN vs. PBE - Sectors Allocation Comparison
Sectors
ICLN
PBE
Utilities
-
Industrials
-
Energy
-
Technology
-
Basic Materials
-
Consumer Cyclical
-
Communication Services
-
-
Consumer Defensive
-
-
Financial Services
-
Healthcare
-
Real Estate
-
-
Utilities
ICLN
PBE
-
Industrials
ICLN
PBE
-
Energy
ICLN
PBE
-
Technology
ICLN
PBE
-
Basic Materials
ICLN
PBE
-
Consumer Cyclical
ICLN
PBE
-
Communication Services
ICLN
-
PBE
-
Consumer Defensive
ICLN
-
PBE
-
Financial Services
ICLN
-
PBE
Healthcare
ICLN
-
PBE
Real Estate
ICLN
-
PBE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ICLN vs. PBE — Risk / Return Rank
ICLN
PBE
ICLN vs. PBE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Global Clean Energy ETF (ICLN) and Invesco Dynamic Biotechnology & Genome ETF (PBE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ICLN | PBE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.38 | ||
| Sortino ratioReturn per unit of downside risk | +0.07 | ||
| Omega ratioGain probability vs. loss probability | 1.35 | 1.31 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 3.77 | 2.92 | +0.85 |
| Martin ratioReturn relative to average drawdown | 13.82 | 8.21 | +5.61 |
Loading charts...
Drawdowns
ICLN vs. PBE - Drawdown Comparison
The maximum ICLN drawdown since its inception was -87.15%, which is greater than PBE's maximum drawdown of -45.69%. Use the drawdown chart below to compare losses from any high point for ICLN and PBE.
Loading charts...
Drawdown Indicators
| ICLN | PBE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.15% | -45.69% | -41.46% |
Max Drawdown (1Y)Largest decline over 1 year | -16.38% | -11.73% | -4.65% |
Max Drawdown (3Y)Largest decline over 3 years | -43.18% | -22.43% | -20.75% |
Max Drawdown (5Y)Largest decline over 5 years | -57.16% | -34.71% | -22.45% |
Max Drawdown (10Y)Largest decline over 10 years | -66.75% | -37.84% | -28.91% |
Current DrawdownCurrent decline from peak | -42.58% | -1.00% | -41.58% |
Average DrawdownAverage peak-to-trough decline | -66.55% | -16.21% | -50.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.46% | 4.17% | +0.29% |
Volatility
ICLN vs. PBE - Volatility Comparison
iShares Global Clean Energy ETF (ICLN) has a higher volatility of 12.94% compared to Invesco Dynamic Biotechnology & Genome ETF (PBE) at 6.04%. This indicates that ICLN's price experiences larger fluctuations and is considered to be riskier than PBE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ICLN | PBE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.94% | 6.04% | +6.90% |
Volatility (6M)Calculated over the trailing 6-month period | 22.57% | 13.67% | +8.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 28.28% | 19.01% | +9.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.55% | 22.48% | +5.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.33% | 24.91% | +2.42% |
ICLN vs. PBE - Expense Ratio Comparison
ICLN has a 0.39% expense ratio, which is lower than PBE's 0.59% expense ratio.
Dividends
ICLN vs. PBE - Dividend Comparison
ICLN's dividend yield for the trailing twelve months is around 1.54%, more than PBE's 1.02% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICLN iShares Global Clean Energy ETF | 1.54% | 1.63% | 1.85% | 1.59% | 0.89% | 1.18% | 0.34% | 1.36% | 2.77% | 2.49% | 3.88% | 2.36% |
PBE Invesco Dynamic Biotechnology & Genome ETF | 1.02% | 1.00% | 0.05% | 0.02% | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% | 0.57% | 0.38% | 1.12% |
Frequently Asked Questions
ICLN and PBE have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ICLN has higher volatility (12.94%) compared to PBE (6.04%). In terms of maximum drawdown, ICLN dropped -87.15% vs PBE's -45.69%.
On 10-year performance, ICLN leads with 11.52% vs 8.90% for PBE. On fees, ICLN is cheaper at 0.39% per year. On volatility, PBE has been the lower-risk option at 6.04%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, ICLN has performed better with a 11.52% return vs 8.90%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
ICLN is cheaper with a 0.39% expense ratio, compared with 0.59% for PBE.
ICLN has the higher dividend yield at 1.54%, compared with 1.02% for PBE.
ICLN is categorized as Alternative Energy Equities, while PBE is Health & Biotech Equities. ICLN tracks S&P Global Clean Energy Index, while PBE tracks Dynamic Biotech & Genome Intellidex Index (AMEX). They also come from different issuers: iShares and Invesco. Their fees differ too: 0.39% for ICLN and 0.59% for PBE.
ICLN currently has the higher Sharpe Ratio (2.19 vs 1.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ICLN and PBE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer